Committed under
Signablok, Inc.
$730,695 committed in all years on record · 0.0% of the program
- Full records
- Signablok, Inc. → everything they’re paid, across every program and agencyCardiovascular Diseases Research → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Cardiovascular Diseases Research dollars committed to Signablok, Inc., per fiscal year.
Awards
The largest awards to Signablok, Inc. under this program.
TREM-1 Therapy for the Treatment of Empyema - Project Summary/abstract the Incidence of Empyema Is Increasing and Associated With a Mortalit…
Sep 10, 2025$457,954
New Mechanism-based TREM-1 Therapy for Acute Respiratory Distress Syndrome - Project Summary/abstract Every Year, 150,000 Americans Are Affe…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants
